Immediate Lymphatic Reconstruction to prevent breast cancer–related lymphedema
Official title: Prospective, Randomized Clinical Trial for Immediate Lymphatic Reconstruction to Prevent Breast Cancer Related Lymphedema
Run by University of South Florida · NCT07127003 · Data updated 2026-11-12
This will test whether doing Immediate Lymphatic Reconstruction during axillary lymph node removal can prevent lymphedema in women at high risk after breast cancer surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | Women only |
| Enrollment | 98 (estimated) |
| Sponsor | University of South Florida Academic / other |
| Drugs / interventions | radiation |
| Locations | 3 sites (Tampa, Florida and 2 other locations) |
| Status | Recruiting |
| Started | October 1, 2025 |
| Main results expected | October 1, 2026 |
| Study ends | October 1, 2027 |
| Registry record updated | April 30, 2026 |
| Trial ID | NCT07127003 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18–75 undergoing or likely to require unilateral axillary lymph node dissection for breast cancer who are identified as high-risk by the tumor board and meet intraoperative criteria for lymphatic bypass are ideal candidates.
✕Probably not a fit
Patients with prior ALND, existing ipsilateral lymphedema, those only treated with sentinel node biopsy, those requiring bilateral ALND, male patients, or non-English speakers (per protocol exclusions) would not be expected to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, blinded trial enrolling high-risk women identified by a multidisciplinary tumor board who are undergoing or likely to require axillary lymph node dissection. Participants undergo baseline lymphedema screening with bioimpedance spectroscopy, circumferential limb measurements, and 3D infrared perometry, then are randomized to ILR performed at the time of ALND or to no ILR. Surgery uses RAM to identify lymphatic channels and a microvascular lymphatic-to-venous bypass is performed when suitable lymphatics and veins are found. The study will compare incidence of breast cancer–related lymphedema, safety outcomes, and patient-reported quality of life between the two arms.
Why it matters
Potential benefit: If successful, adding ILR at the time of axillary dissection could substantially reduce the rate of lymphedema and help preserve arm function and quality of life for high-risk patients.
How similar studies have gone: Single-center and observational series of immediate lymphatic reconstruction (LYMPHA) have reported lower lymphedema rates, but randomized data remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients consenting for unilateral ALND \[prior history of sentinel lymph node biopsy (SLNBx) allowed if \<6 months from consent\] * Patients consenting for unilateral SLNBx with possible ALND, with a clinically or radiographically positive lymph node OR a high likelihood of ALND per the Breast Surgeon * Identification of at least one transected lymphatic channel and at least one vein to be used for bypass at the time of ALND during surgery * Female breast cancer patients 18-75 years of age (inclusive) Exclusion Criteria: * • Male breast cancer patients * Non-English speaking participants * Female breast cancer patients with axillary recurrence * Female breast cancer patients who have a history of ALND * Female patients requiring bilateral ALND for the treatment of their breast cancer * Female breast patients treated with SLNBx only * Primary lymphedema of the affected upper limb * Secondary lymphedema of the affected limb prior to the lymphadenectomy * Radiotherapy at the axilla before the study / surgery * Life expectancy \< 2 years for any reason * Pregnancy or nursing * Substance abuse (such as alcohol or drug abuse) within 6 months prior to screening * Severe psychiatric disease * Distant metastases at the time of preoperative screening
Where it's running
-
Tampa General Hospital
Tampa, Florida, United States Recruiting -
Moffitt Cancer Center
Tampa, Florida, United States Recruiting -
University of South Florida
Tampa, Florida, United States Recruiting
Study contacts
- Study coordinator: NIcholas Panetta, MD
- Email: panetta@usf.edu
- Phone: 8134868073
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Axillary Web Syndrome after Breast Cancer Surgery: Incidence, Risk Factors, and Outcomes
This study tests how often AWS occurs after breast cancer surgery and what factors make it more likely, using a forward-looking approach in women undergoing SLNB or ALND.
-
Screening for Breast Cancer-Related Lymphedema in Targeted Therapy
This study tests whether targeted breast cancer therapies are linked to lymphedema by tracking arm volume and symptoms in women undergoing treatment.
-
ESWT added to standard lymphedema care for breast cancer patients
This study tests whether adding extracorporeal shock wave therapy to standard lymphedema care helps women with unilateral Stage II breast cancer–related swelling.
-
Pneumatic compression versus manual lymph drainage as part of decongestive care for breast cancer–related lymphedema
This study tests whether adding or replacing manual lymph drainage with intermittent pneumatic compression helps women with unilateral breast cancer–related arm lymphedema.
-
Kinesio taping for chronic breast and truncal oedema after breast cancer treatment
This trial tests whether adding kinesio tape to standard decongestive lymphatic therapy helps women with persistent (more than 6 months) breast or truncal swelling after breast cancer treatment.
-
Effects of physiotherapy on sleep and quality of life in women with lymphedema after breast cancer
This study is testing whether special physiotherapy can help women with lymphedema after breast cancer feel better and sleep more soundly.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.